ClinicalTrials.Veeva

Menu

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

A

Abionic

Status

Completed

Conditions

Sepsis Bacterial
Sepsis

Treatments

Device: Blood Sampling

Study type

Observational

Funder types

Industry

Identifiers

NCT05627076
AB-PSP-006

Details and patient eligibility

About

Abionic has developed a targeted, rapid test for pancreatic stone protein (PSP) in human K2-EDTA venous whole blood using the abioSCOPE instrument.

Currently no PSP study comparaison has been done between venous and arterial whole blood. Abionic would like to confirm the equivalence of the PSP between venous whole blood and arterial whole blood.

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Provide signed and dated written informed consent by patient or close / family / trusted person prior to any mandatory study-specific procedures, sample collection, or analysis;
  2. Male or female, 18 years of age or older;
  3. Patient admitted to hospital
  4. Need for venous and arterial blood samples as part of standard of care
  5. Covered by a social security scheme.

Exclusion criteria

  1. Subject suffering from a hematological pathology (coagulation disorder, severe anemia) that could interfere with the blood draw procedure;
  2. Subject under juridical protection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems